Log In
Print this Print this

Recombinant C1 esterase inhibitor

  Manage Alerts
Collapse Summary General Information
Company iBio Inc.
DescriptionPlasma-derived C1 esterase inhibitor
Molecular Target Carboxylesterase 1 (CES1) (hCE1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today